Biotage AB (publ)
BITGF · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $385,000 | $582,000 | $490,000 | $504,000 |
| % Growth | -33.8% | 18.8% | -2.8% | – |
| Cost of Goods Sold | $143,000 | $222,000 | $187,000 | $180,000 |
| Gross Profit | $242,000 | $360,000 | $303,000 | $324,000 |
| % Margin | 62.9% | 61.9% | 61.8% | 64.3% |
| R&D Expenses | $43,000 | $51,000 | $41,000 | $45,000 |
| G&A Expenses | $85,000 | $72,000 | $68,000 | $63,000 |
| SG&A Expenses | $203,000 | $202,000 | $194,000 | $203,000 |
| Sales & Mktg Exp. | $118,000 | $130,000 | $126,000 | $140,000 |
| Other Operating Expenses | $8,000 | -$68,000 | $3,000 | $80,000 |
| Operating Expenses | $254,000 | $185,000 | $238,000 | $328,000 |
| Operating Income | -$12,000 | $175,000 | $65,000 | -$4,000 |
| % Margin | -3.1% | 30.1% | 13.3% | -0.8% |
| Other Income/Exp. Net | $16,000 | -$17,000 | -$4,000 | $72,000 |
| Pre-Tax Income | $4,000 | $158,000 | $61,000 | $68,000 |
| Tax Expense | $0 | -$1,000 | $16,000 | $20,000 |
| Net Income | $4,000 | $159,000 | $45,000 | $48,000 |
| % Margin | 1% | 27.3% | 9.2% | 9.5% |
| EPS | 0.05 | 1.99 | 0.55 | 0.6 |
| % Growth | -97.5% | 261.8% | -8.3% | – |
| EPS Diluted | 0.05 | 1.98 | 0.56 | 0.6 |
| Weighted Avg Shares Out | 80,049 | 80,049 | 81,818 | 80,008 |
| Weighted Avg Shares Out Dil | 80,182 | 80,171 | 80,114 | 80,049 |
| Supplemental Information | – | – | – | – |
| Interest Income | $15,885 | $0 | $0 | $0 |
| Interest Expense | $0 | $16,926 | $3,952 | $8,934 |
| Depreciation & Amortization | $40,000 | $47,000 | $46,000 | $46,000 |
| EBITDA | $28,000 | $222,000 | $111,000 | $123,000 |
| % Margin | 7.3% | 38.1% | 22.7% | 24.4% |